Coagulation Factor X Products

Antibodies
Coagulation Factor X Antibody ...
Coagulation Factor X Antibody - BS...
NBP1-33320
Species: Hu, Mu, RM
Applications: WB, ICC/IF, IHC
Host: Rabbit Polyclonal
Antibody Pairs
Coagulation Factor X Antibody ...
Coagulation Factor X Antibody Pair...
NBP2-79342
Species: Hu
Applications: ELISA
Host: Monoclonal
Conjugate Catalog # Availability Size Price
ELISA Kits
Human Coagulation Factor X EL ...
Human Coagulation Factor X ELISA K...
NBP2-60625
Species: Hu
Applications: ELISA
Rat Coagulation Factor X ELIS ...
Rat Coagulation Factor X ELISA Kit...
NBP2-82526
Species: Rt
Applications: ELISA
Monkey Coagulation Factor X E ...
Monkey Coagulation Factor X ELISA ...
NBP2-82394
Species: Pm
Applications: ELISA
Lysates
Coagulation Factor X Overexpr ...
Coagulation Factor X Overexpressio...
NBL1-10402
Species: Hu
Applications: WB
Proteins
Recombinant Human Coagulation ...
Recombinant Human Coagulation Fact...
1063-SE
Species: Hu
Applications: Enzyme Activity
Formulation Catalog # Availability Price  
Recombinant Mouse Coagulation ...
Recombinant Mouse Coagulation Fact...
6724-SE
Species: Mu
Applications: Enzyme Activity
Formulation Catalog # Availability Price  
Recombinant Human Activated C ...
Recombinant Human Activated Coagul...
ACFP1063
Species: Hu
Applications: Enzyme Activity

Description

Chimera RNA interference (chimera RNAi) is process by which small interfering RNA/DNA chimera triggers the destruction of mRNA for the original gene.  The discovery work, design, and application of chimera RNAi has been pioneered by Professor Kaoru Saigo and Dr. Kumiko Ui-Tei at the University of Tokyo.  Chimera RNAi has many advantages over the conventional siRNAs.  First, it has been demonstrated to have reliable knock-down for over 10,000 human genes.  Because the human genome is composed of an intricate, genetic network, chimera RNAi’s unique design has successfully obviated the off-target effects including microRNA-based influence.  Another advantage of the chimera RNAi technology is its effectiveness at low concentrations (0.5nM to 5nM); only mRNA is destroyed so genomic genes are not affected.  Finally, having both the sense and anti-sense strands consisting RNA/DNA chimera, it offers much greater compound stability for streamlining in vitro and in vivo assays and applications while minimizing interferon induction and other adverse reactions.

Bioinformatics

Product By Gene ID 2159
Alternate Names
  • Cf10
  • Coagulation Factor X
  • EC 3.4.21
  • EC 3.4.21.6
  • F10
  • factor Xa
  • FX
  • FXa
  • Prothrombinase
  • Stuart Factor
  • Stuart-Prower factor